Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...

Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.

Sleep apnea could be costing you brain power and increasing your risk of dementia and Alzheimer's disease, a new study says.

Dr. Katherine Saunders, at Weill Cornell Medicine, joined ABC News' to discuss a new daily weight loss pill by Eli Lilly saying it "opens up opportunities" to treat diseases. Dr. Rekha Kumar ...

Indianapolis-based Eli Lilly & Co. announced promising results from a large study of its own tablet in diabetes patients last ...

Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes ... Type 2 diabetes, sleep apnea or heart disease.

Some steps that a person can take to lose weight include: In addition to lifestyle changes that promote weight loss ... doctors may also recommend surgery to treat sleep apnea, especially in ...

While initially developed to treat Type 2 diabetes, GLP-1 drugs have surged in popularity for their ability to drive substantial weight loss ... conditions like sleep apnea and heart disease.

A new weight-loss pill taken daily could compete with injections like Ozempic, research suggests. Patients, who all were obese and suffered from type 2 diabetes, took orforglipron for nine months as ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.